Health ❯ Healthcare ❯ Cardiovascular Health

Risk Factors

Weight Management Blood Pressure Management Hypertension Left Ventricle Mass Cardiovascular Events Symptoms Awareness Alcohol Consumption Sedentary Lifestyle hsCRP Levels Medication Effects Hypertension Treatment Glycemic Control Cardiovascular Disease

Ventyx’s NLRP3 Drug Cuts Inflammation Markers in Phase 2, Shares Soar

Strong biomarker reductions have investors eyeing a cardiovascular push for the oral NLRP3 candidate.

New U.S. Blood Pressure Guidelines Urge Earlier Treatment as Study Backs Lower Targets

Glipizide Linked to 13% Higher Cardiovascular Risk Than DPP-4 Inhibitors

Hypertension Canada Releases New Guideline for Primary Care Management